# Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis

> **NCT02151734** · PHASE3 · COMPLETED · sponsor: **Korea United Pharm. Inc.** · enrollment: 242 (actual)

## Conditions studied

- Acute Bronchitis

## Interventions

- **DRUG:** KALOMIN™ Tab.
- **DRUG:** Umckamin syrup

## Key facts

- **NCT ID:** NCT02151734
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-12
- **Final completion:** —
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2014-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151734, "Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02151734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*